BAWAG Group AG (BG)
Vienna Exchange · Austria · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 155.40 |
|---|---|
| 52-week range | 106.70 – 184.60 |
| Return, 1 month / 3 months | −12.2% / −9.2% |
| Return, 1 year / 3 years | +49.7% / +364.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 31 |
| Volatility (1 year) | 26.4% |
| Worst drawdown (1 year) | -16.6% |
| Average daily value traded | 20.75M EUR |
| Dividend yield | 4.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BAWAG Group AG is an Austrian bank based in Vienna. It provides retail banking services to individuals and small and medium-sized businesses, including savings and current accounts, consumer loans, mortgages, credit cards and leasing. The group also offers corporate lending and financial services to commercial clients. Its operations are concentrated in Austria, with additional activities in Germany and other European markets, serving customers through branch networks and digital channels.
On this site BAWAG Group AG appears as a stock on the Vienna Exchange (Austria), code BG, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BAWAG Group AG (BG) trades on the Vienna Exchange in Austria. It last closed at EUR 155.40 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 17 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 49.7% and over the last three months it fell 9.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Vienna Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.6% | ||
| From 52-week high | -15.8% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.2% | ||
| 6-month return | 5.9% | ||
| 12-month return, skipping the last month | 70.6% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.6% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 20.75M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −7.7% |
|---|---|
| 1 month | −12.2% |
| 3 months | −9.2% |
| 6 months | +5.9% |
| 1 year | +49.7% |
| 3 years | +364.8% |
| 5 years | +294.9% |
Signals
| 50-day / 200-day average | 174.74 / 154.48 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | EUR 6.2500 |
| 8 Apr 2025 | EUR 5.5000 |
| 10 Apr 2024 | EUR 5.0000 |
| 4 Apr 2023 | EUR 3.7000 |
| 1 Apr 2022 | EUR 3.0000 |
| 6 Oct 2021 | EUR 4.7218 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.